J
Jung Ho Sohn
Researcher at Yonsei University
Publications - 41
Citations - 700
Jung Ho Sohn is an academic researcher from Yonsei University. The author has contributed to research in topics: Population & Inflammation. The author has an hindex of 16, co-authored 37 publications receiving 567 citations. Previous affiliations of Jung Ho Sohn include UPRRP College of Natural Sciences & Hanyang University.
Papers
More filters
Journal ArticleDOI
Glutathione Peroxidase 1 Deficiency Attenuates Allergen-Induced Airway Inflammation by Suppressing Th2 and Th17 Cell Development
Hee Yeon Won,Jung Ho Sohn,Hyun Jung Min,Kihyun Lee,Hyun Ae Woo,Ye-Shih Ho,Jung Won Park,Sue Goo Rhee,Eun Sook Hwang +8 more
TL;DR: Data indicate that GPx1-dependent control of intracellular ROS accumulation is important not only for regulation of Th cell proliferation but for modulation of differentiation into Th1, Th2, and Th17 cells.
Journal ArticleDOI
Acute exposure to silica nanoparticles aggravate airway inflammation: different effects according to surface characteristics.
Hye Jung Park,Jung Ho Sohn,Yoon Ju Kim,Yoon Hee Park,Heejae Han,Kyung Hee Park,Kang Taek Lee,Hoon Choi,Kiju Um,In Hong Choi,Jung Won Park,Jae Hyun Lee +11 more
TL;DR: In this paper, the effects of acute exposure to silica nanoparticles, either alone or in conjunction with ovalbumin (OVA), by studying the respiratory systems in exposed mouse models were examined.
Journal ArticleDOI
Obesity Increases Airway Hyperresponsiveness via the TNF-α Pathway and Treating Obesity Induces Recovery
TL;DR: It is suggested that restoring normal body weight is an appropriate strategy for reducing TNF-α levels, and controlling inflammation may help improve asthma severity and control in obesity-related asthma.
Acute exposure to silica nanoparticles aggravate airway inflammation: different effects according to surface characteristics
Hye Jung Park,Jung Ho Sohn,Yoon Ju Kim,Yoon Hee Park,Heejae Han,Kyung Hee Park,Kang Taek Lee,Hoon Choi,Kiju Um,In Hong Choi,Jung Won Park,Jae Hyun Lee +11 more
TL;DR: Increased airway inflammation was associated with acute SNPs exposure, whether exposed solely to SNPs or SNPs in conjunction with OVA, and P-SNPs appear to be relatively safer for clinical use than S- SNPs and M-SNP, as determined by lower observed toxicity and airway system inflammation.
Journal ArticleDOI
A phase II randomized trial of cobimetinib plus chemotherapy, with or without atezolizumab, as first-line treatment for patients with locally advanced or metastatic triple-negative breast cancer (COLET): primary analysis.
Adam Brufsky,S.-B. Kim,Ž. Zvirbule,Alexandru Eniu,Jeroen Mebis,Jung Ho Sohn,Matthew Wongchenko,Saibah Chohan,R. Amin,Yibing Yan,V. McNally,David Miles,Sherene Loi +12 more
TL;DR: The COLET study as discussed by the authors evaluated first-line cobimetinib plus chemotherapy, with or without atezolizumab, in patients with locally advanced or metastatic triple-negative breast cancer.